Brenig Therapeutics
Brenig Therapeutics is a US startup, founded in 2021. It has raised at least $30.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Brenig Therapeutics has raised at least $30.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
Related
Questions and answers
What does Brenig Therapeutics do?
Brenig Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Brenig Therapeutics raised?
At least $30.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Brenig Therapeutics based?
Brenig Therapeutics is registered in United States; its operating headquarters is not yet confirmed.
When was Brenig Therapeutics founded?
Brenig Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.